Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma.
Niwa K, Kawakita D, Nagao T, Takahashi H, Saotome T, Okazaki M, Yamazaki K, Okamoto I, Hirai H, Saigusa N, Fushimi C, Masubuchi T, Miura K, Okazaki SI, Matsui H, Okada T, Iwaki S, Matsuki T, Hanyu K, Tsukahara K, Oridate N, Tada Y. Niwa K, et al. Among authors: oridate n. Sci Rep. 2020 Oct 12;10(1):16988. doi: 10.1038/s41598-020-73965-6. Sci Rep. 2020. PMID: 33046752 Free PMC article.
Risk factors for post-tonsillectomy hemorrhage.
Ikoma R, Sakane S, Niwa K, Kanetaka S, Kawano T, Oridate N. Ikoma R, et al. Among authors: oridate n. Auris Nasus Larynx. 2014 Aug;41(4):376-9. doi: 10.1016/j.anl.2014.02.007. Epub 2014 Mar 3. Auris Nasus Larynx. 2014. PMID: 24602696
Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
Nishimura G, Komatsu M, Hata M, Yabuki K, Taguchi T, Takahashi M, Shiono O, Sano D, Arai Y, Takahashi H, Chiba Y, Oridate N. Nishimura G, et al. Among authors: oridate n. Int J Clin Oncol. 2016 Apr;21(2):224-230. doi: 10.1007/s10147-015-0890-8. Epub 2015 Aug 14. Int J Clin Oncol. 2016. PMID: 26272533
Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma.
Nishimura G, Taguchi T, Takahashi M, Shiono O, Komatsu M, Sano D, Yabuki K, Arai Y, Takahashi H, Hata M, Oridate N. Nishimura G, et al. Among authors: oridate n. Cancer Chemother Pharmacol. 2016 Jun;77(6):1315-9. doi: 10.1007/s00280-016-3052-4. Epub 2016 May 6. Cancer Chemother Pharmacol. 2016. PMID: 27154176 Clinical Trial.
186 results